Team develops next-generation wearable continuous glucose monitoring system for diabetes management
Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...
GlobalData on MSN5h
Senseonics and Ascensia announce FDA approval for one-year CGM system
Medical technology companies Senseonics and Ascensia Diabetes Care have announced receipt of the US Food and Drug ...
Le Lézard5h
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. , the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company's groundbreaking NIL ...
BioWorld18h
FDA clears Senseonic’s Eversense one-year implantable CGM
The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a ...
drugdeliverybusiness21h
Senseonics wins FDA nod for 365-day implantable CGM
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
Becker's Hospital Review23h
Glucose monitor receives FDA clearance
The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...
Researchers present ranges of normal glucose levels among non-diabetic adults wearing continuous glucose monitors
New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are ...